Literature DB >> 20809774

Historical evolution in the understanding of Stargardt macular dystrophy.

Gerald Allen Fishman1.   

Abstract

The historical evolution in the understanding of Stargardt macular dystrophy (fundus flavimaculatus) from the initial description by Karl Stargardt, identification of mutations in the ABCA4 gene, to the development of a mouse model for the human disease, is described. Highlighted are the studies by several investigators whose contributions illuminated the path to our current understanding of Stargardt disease and helped to advance progress toward future therapeutic trials for the unfortunate group of patients afflicted with this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809774     DOI: 10.3109/13816810.2010.499887

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  4 in total

Review 1.  Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.

Authors:  Pasqualina Colella; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

2.  Rod photoreceptor temporal properties in retinal degenerative diseases.

Authors:  Yuquan Wen; Kirsten G Locke; Donald C Hood; David G Birch
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Inner and outer retinal changes in retinal degenerations associated with ABCA4 mutations.

Authors:  Wei Chieh Huang; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Rebecca Sheplock; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 4.  Nanotechnology and nanotoxicology in retinopathy.

Authors:  Dong Hyun Jo; Tae Geol Lee; Jeong Hun Kim
Journal:  Int J Mol Sci       Date:  2011-11-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.